Course Content
Course overview
A brief overview of the course purpose, instructors and purpose.
0/4
HIV Fundamentals (EPA N/A)
Build a solid foundation in HIV science (50 questions)
0/6
HIV Prevention in Adults and Children (EPA 1.1)
Master HIV prevention strategies, counselling, and ethical issues with targeted questions and detailed explanations (50 questions)
0/6
HIV in Children (EPA 3.1 & 3.3)
Master the essentials of paediatric HIV care from diagnosis to treatment failure management (90 questions)
0/7
Prevention of Vertical Transmission (EPA 4.1)
Learn to prevent vertical HIV transmission through quality maternal and neonatal care (60 questions)
0/5
Tuberculosis & HIV Co-infection in Adults (EPA 5.1)
Diagnose and manage TB in adults with HIV, including extrapulmonary and drug-resistant forms (60 questions)
0/5
Tuberculosis & HIV Co-infection in Children (EPA 3.3 & 3.4)
Understand TB care in HIV-positive children with emphasis on child-specific approaches (60 questions)
0/5
HIV and the Nervous System (EPA 5.2, 5.9)
Recognise and manage neurological complications in people living with HIV (55 questions)
0/6
HIV and the Gastrointestinal Tract (EPA 5.3, 5.5 & 6.1)
Manage gastrointestinal and liver conditions in HIV, including ART implications (50 questions)
0/6
HIV and the Respiratory System (EPA: 3.3 & 5.4)
Approach HIV-associated respiratory illness with integrated diagnostic and treatment strategies (45 questions)
0/5
Dermatologic & Mucocutaneous Conditions in HIV (EPA 5.5 & 5.6)
Identify and manage HIV-related skin conditions and drug reactions (40 questions)
0/5
Mental Health and HIV (EPA 5.7)
Address mental health in HIV care with screening and integrated support (45 questions)
0/5
Malignancies in HIV (EPA 5.8)
Manage HIV-associated cancers with a focus on early identification and integrated care (25 questions)
0/3
HIV and Haematology (EPA 6.2)
Recognise and manage haematological complications of HIV and its treatment (25 questions)
0/3
HIV and Co-morbidities (EPA 6.1, 6.3, 6.5, 7.1)
Coordinate HIV care in patients with chronic comorbidities (50 questions)
0/6
Treatment Failure in Adults and Children (EPA 2.2, 3.2)
Gain confidence in identifying and managing ART failure in adults and children (50 questions)
0/6
Advanced HIV Disease (EPA N/A)
Build your knowledge in managing advanced HIV illness across multiple domains (55 questions)
0/7
Antiretroviral Drugs (6.4)
Build confidence in understanding ART through clinical cases covering drug classes, side effects, and interactions (60 questions)
0/7
Adherence, Retention in Care & Key Populations (EPA 8.1)
Strengthen your approach to HIV adherence and retention with tailored strategies for diverse populations (35 questions)
0/4
Course Completion & Next Steps
0/1
HIV Diploma Review & Practice Course
About Lesson

Common Abbreviations in HIV Care

This section provides a comprehensive list of abbreviations and acronyms commonly used in HIV care and treatment. It is designed to support learners in navigating clinical guidelines, research articles, patient records, and examination materials. The questions in this course also make frequent use of these terms, reflecting real-world clinical language and guideline-based practice. Familiarity with these abbreviations is essential for clear communication, accurate interpretation of clinical documentation, and successful completion of the HIV Diploma. The list includes drug names, laboratory terms, clinical concepts, programme-related terminology, and common abbreviations from South African and international HIV management guidelines.

Core HIV-Related Abbreviations

  • AHD: Advanced HIV Disease
  • AIDS: Acquired Immune Deficiency Syndrome
  • ART: Antiretroviral Therapy
  • ARV: Antiretroviral
  • CD4: Refers to CD4+ T cells
  • HIV: Human Immunodeficiency Virus
  • IRIS: Immune Reconstitution Inflammatory Syndrome
  • MSM: Men who have sex with men
  • OI: Opportunistic Infection
  • PLHIV: People Living with HIV
  • VL: Viral Load

Common Antiretrovirals and ART Regimens

  • 3TC: Lamivudine
  • ABC: Abacavir
  • ATV/r: Atazanavir/ritonavir
  • AZT or ZDV: Zidovudine
  • DRV/r: Darunavir/ritonavir
  • DTG: Dolutegravir
  • EFV: Efavirenz
  • FTC: Emtricitabine
  • LPV/r: Lopinavir/ritonavir
  • NVP: Nevirapine
  • pDTG: paediatric Dolutegravir 
  • RAL: Raltegravir
  • RPV: Rilpivirine
  • TAF: Tenofovir Alafenamide
  • TDF: Tenofovir Disoproxil Fumarate
  • TLD: Tenofovir, Lamivudine, Dolutegravir

Treatment Class Abbreviations

  • CCR5 antagonist: Chemokine Coreceptor 5 Antagonist
  • FI: Fusion Inhibitor
  • INSTI: Integrase Strand Transfer Inhibitor
  • NNRTI: Non-Nucleoside Reverse Transcriptase Inhibitor
  • NRTI: Nucleoside Reverse Transcriptase Inhibitor
  • PI: Protease Inhibitor

Diagnostic and Laboratory Abbreviations

  • AFP: Alpha fetoprotein
  • ALT: Alanine Aminotransferase
  • AST: Aspartate Aminotransferase
  • CD4: CD4 T-cell Count
  • CrCl: Creatinine Clearance
  • CRP: C-Reactive Protein
  • CSF: Cerebrospinal Fluid
  • CT: Computed Tomography
  • DEXA: Dual-Energy X-ray Absorptiometry
  • DNA PCR: Deoxyribonucleic Acid Polymerase Chain Reaction
  • DST: Drug Susceptibility Testing
  • ECG: Electrocardiogram
  • FBC: Full Blood Count
  • GCS: Glasgow Coma Scale
  • GFR: Glomerular Filtration Rate
  • GXP: GeneXpert MTB/RIF Assay
  • Hb: Haemoglobin
  • IGRA: Interferon Gamma Release Assay
  • INR: International Normalised Ratio
  • IU/L: International Units per Litre
  • LFT: Liver Function Test
  • LLN: Lower Limit of Normal
  • LPA: Line Probe Assay
  • MRI: Magnetic Resonance Imaging
  • NAAT: Nucleic Acid Amplification Test
  • PCR: Polymerase Chain Reaction
  • QTc: Corrected QT Interval
  • RNA PCR: Ribonucleic Acid Polymerase Chain Reaction
  • RPR: Rapid Plasma Reagin 
  • U&E: Urea and Electrolytes
  • ULN: Upper Limit of Normal
  • VL: Viral Load
  • WCC: White Cell Count

Tuberculosis and TB-HIV Co-Management

  • 3HP: 3 Months Isoniazid + Rifapentine
  • 3RH: 3 Months Rifampicin + Isoniazid
  • 6H: 6 Months of Isoniazid Monotherapy 
  • AT-DILI: Anti-Tuberculous Drug-Induced Liver Injury
  • BCG: Bacille Calmette–Guérin (TB vaccine)
  • BDQ: Bedaquiline
  • BPaL-L: Bedaquiline, Pretomanid, Linezolid, Levofloxacin
  • BPaLM: Bedaquiline, Pretomanid, Linezolid, Moxifloxacin
  • DILI: Drug-Induced Liver Injury
  • EPTB: Extrapulmonary Tuberculosis
  • INH: Isoniazid
  • IPT: Isoniazid preventative therapy
  • LAM: Lipoarabinomannan 
  • Pa: Pretomanid
  • RHZE: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol
  • Rif: Rifampicin
  • RR-TB: Rifampicin-Resistant Tuberculosis
  • TBM: Tuberculous Meningitis
  • TPT: TB preventative therapy

Clinical Management and Monitoring

  • DC: Dispensing Cycle
  • DMOC: Differentiated models of care
  • EAC: Enhanced Adherence Counselling
  • EX-PUP: External pick-up point
  • FAC-PUP: Facility pick-up point
  • PUP: Pick-up point
  • RPC: Repeat Prescription Collection

Infections and Co-infections

  • CMV: Cytomegalovirus
  • CrAg: Cryptococcal Antigen
  • EBV: Epstein–Barr Virus
  • HBsAg: Hepatitis B Surface Antigen
  • HBV: Hepatitis B Virus
  • HCV: Hepatitis C Virus
  • HCV ab: Hepatitis C virus antibody
  • MAC: Mycobacterium Avium Complex
  • PJP: Pneumocystis Jirovecii Pneumonia
  • VZV: Varicella Zoster Virus

Comorbidities and Complications 

  • AKI: Acute Kidney Injury 
  • CKD: Chronic Kidney Disease
  • DRESS: Drug Reaction with Eosinophilia and Systemic Symptoms 
  • HIVAN: HIV-Associated Nephropathy
  • ITP: Immune thrombocytopaenic purpura
  • TTP: Thrombotic thrombocytopaenic purpura
0% Complete